The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) and the U.S. Food and Drug Administration (FDA) Office of Chief Scientist (OCS) are hosting an informational workshop on June 21, 2011 at the Executive Conference Center (ECC) at Liberty Center in Arlington, VA. The purpose of the workshop is to discuss the scientific advancements that are needed, and the technical and regulatory challenges that must be overcome, for the development of human-relevant preclinical platforms for efficacy and toxicology testing.
See attached DARPA-SN-11-37
Bid Protests Not Available